Cartridge with Bedrocan® cannabis gets EU-GMP-certification

Med-tech company Syqe has reached an important milestone: The cartridge containing Bedrocan’s standardised cannabis has recently received EU-GMP (good manufacturing practice) certification. This cartridge is a vital component of the advanced SyqeAir Inhaler, a device that delivers metered and consistent doses of THC and cannabinoids from full-spectrum cannabis in aerosol form.

The cartridge includes sixty standardised cannabis units (VaporChips), filled with Bedrocan®, a cannabis product that has been produced under GMP guidelines since 2017. Manufacturers seeking to market products in the European Union must comply with EU-GMP guidelines, which are among the strictest in the world. Bedrocan also follows similar guidelines for medicinal cannabis cultivation, known as Good Medicinal Cannabis Cultivation Practices (GMCCP).

Landmark achievement

Hagit Kamin, CEO of SyqeAir: “Receiving the EU-GMP certification is a landmark achievement for both SyqeAir and the medical cannabis industry. It underscores our unwavering commitment to safety, quality, and efficacy in delivering therapeutic solutions. This certification is a testament to our dedication to providing patients and healthcare professionals with an innovative, clinically validated platform for cannabis-based treatments.”

SyqeAir cartridges are manufactured at the company’s production site in Israel. For Syqe, this milestone is significant as it enables the company to market the device and cartridges in countries that adhere to EU-GMP guidelines.